Clinical Trial Update: Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM [Phase 2]

View source ↗

Summary

A Phase 2 trial of PE0139 Injection for Type 2 Diabetes Mellitus has completed, summarizing safety, tolerability, pharmacokinetics and pharmacodynamics in adult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PE0139 (PE0139)

Snippet

Sponsor: PhaseBio Pharmaceuticals Inc. | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED